Page last updated: 2024-10-27

fluoxetine and Paralysis

fluoxetine has been researched along with Paralysis in 3 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research Excerpts

ExcerptRelevanceReference
" We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human intravenous immunoglobulin (hIVIG), (2) fluoxetine, and (3) dexamethasone."3.85Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis. ( Clarke, P; Hixon, AM; Tyler, KL, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hixon, AM1
Clarke, P1
Tyler, KL1
Bermingham, DP1
Hardaway, JA1
Snarrenberg, CL1
Robinson, SB1
Folkes, OM1
Salimando, GJ1
Jinnah, H1
Blakely, RD1
Seliger, GM1
Hornstein, A1

Other Studies

3 other studies available for fluoxetine and Paralysis

ArticleYear
Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
    The Journal of infectious diseases, 2017, 12-05, Volume: 216, Issue:10

    Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Dexamethasone; Disease Models, Animal; Enterov

2017
Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.
    Neurochemistry international, 2016, Volume: 98

    Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopamine Plasma Membrane

2016
Serotonin, fluoxetine, and pseudobulbar affect.
    Neurology, 1989, Volume: 39, Issue:10

    Topics: Aged; Behavior; Fluoxetine; Humans; Male; Paralysis; Serotonin Antagonists

1989